Approval · Notice of Compliance 7098 · 2005
NORVASC: Notice of Compliance 7098
Issued June 14, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7098
- Date
- June 14, 2005
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of paediatric information to the product monograph
- Therapeutic class
- Antihypertensive-antianginal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORVASC | Not yet assigned | — |
Medicinal ingredients
- AMLODIPINE BESYLATE 2.5 MG per TAB
- AMLODIPINE BESYLATE 5 MG per TAB